Search alternatives:
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
mg decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 661 - 680 results of 103,597 for search '(( 50 ((nn decrease) OR (we decrease)) ) OR ( 5 ((mg decrease) OR (a decrease)) ))', query time: 1.39s Refine Results
  1. 661
    Effect of MN705 treatment on TGF-

    Effect of MN705 treatment on TGF- by Wencheng Jin (13136262)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 662
    The screening process of MN705.

    The screening process of MN705. by Wencheng Jin (13136262)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 663
    Changes associated with kidney fibrosis and effects of MN705 treatment on TGF-

    Changes associated with kidney fibrosis and effects of MN705 treatment on TGF- by Wencheng Jin (13136262)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 664
    Plasticity of spatial repellency behaviors in Aedes aegypti<sup>1</sup> females exposed to volatile transfluthrin (1.35 mg/m3).

    Plasticity of spatial repellency behaviors in Aedes aegypti<sup>1</sup> females exposed to volatile transfluthrin (1.35 mg/m3). by Joseph M. Wagman (725058)

    Published 2015
    Save to List
    Saved in:
  5. 665
    KOR-agonist (U50'488) and MOR-agonist (DAMGO) decrease symptoms in OVA-allergic mice.

    KOR-agonist (U50'488) and MOR-agonist (DAMGO) decrease symptoms in OVA-allergic mice. by Swantje C. Duncker (154707)

    Published 2012
    Save to List
    Saved in:
  6. 666
    Immunoblotting for insulin sensitivity markers.

    Immunoblotting for insulin sensitivity markers. by Dwight D. Harris (14484648)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  7. 667
    S3 Data -

    S3 Data - by Dwight D. Harris (14484648)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  8. 668
    S2 Data -

    S2 Data - by Dwight D. Harris (14484648)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  9. 669
    S1 Data -

    S1 Data - by Dwight D. Harris (14484648)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  10. 670
    S4 Data -

    S4 Data - by Dwight D. Harris (14484648)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 671
    Immunoblotting for TGF-beta, alpha-actinin, MMP-13, and mTOR.

    Immunoblotting for TGF-beta, alpha-actinin, MMP-13, and mTOR. by Dwight D. Harris (14484648)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  12. 672
    Immunoblotting for JAK, STAT, and SMAD.

    Immunoblotting for JAK, STAT, and SMAD. by Dwight D. Harris (14484648)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  13. 673
    Fibrosis and TUNEL staining.

    Fibrosis and TUNEL staining. by Dwight D. Harris (14484648)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  14. 674
    Plasmid and genomic changes detected in de-evolution trials.

    Plasmid and genomic changes detected in de-evolution trials. by Irina V. Bakhlanova (2636080)

    Published 2016
    Save to List
    Saved in:
  15. 675
    Fibrosis markers.

    Fibrosis markers. by Dwight D. Harris (14484648)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  16. 676
    Immunoblotting FOXO1 and insulin receptors.

    Immunoblotting FOXO1 and insulin receptors. by Dwight D. Harris (14484648)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  17. 677
    Decrease in the hemolymph sugar level of hyperglycemic silkworms and increase in Akt phosphorylation in the fat body by human insulin.

    Decrease in the hemolymph sugar level of hyperglycemic silkworms and increase in Akt phosphorylation in the fat body by human insulin. by Yasuhiko Matsumoto (206628)

    Published 2011
    Save to List
    Saved in:
  18. 678
    Initial RBC dominant clot compaction in the <i>in vitro</i> MCA model without and with collateral with alteplase applied at clinically relevant concentration (1.3 mg L<sup>-1</sup>).

    Initial RBC dominant clot compaction in the <i>in vitro</i> MCA model without and with collateral with alteplase applied at clinically relevant concentration (1.3 mg L<sup>-1</sup>... by Sandra Thalerová (11434762)

    Published 2024
    Save to List
    Saved in:
  19. 679
    LuxR G37V has decreased DNA-binding activity.

    LuxR G37V has decreased DNA-binding activity. by Chelsea A. Simpson (9579303)

    Published 2024
    Save to List
    Saved in:
  20. 680
    Growth disadvantage conferred by RecA D112R.

    Growth disadvantage conferred by RecA D112R. by Irina V. Bakhlanova (2636080)

    Published 2016
    Save to List
    Saved in:

Search Tools: